Note that the Masimo trade secret lawsuit against Apple is separate from both an ITC injunction preventing the sale of Apple ...

It was really about the O2 sensor patent infringement case Masimo brought against Apple. In theory, that’s a completely unrelated case. In practice, not so much. If you need a quick recap ...

Apple and Masimo's patent and trade secret dispute has intensified through lawsuits as Apple defends its innovations and ...

Apple and Masimo’s legal battle over the Apple Watch’s Blood Oxygen sensing feature continues this week as both firms meet in ...

The retrial came less than a week after Time Magazine named Masimo’s W1 Medical Watch one of the best inventions of 2024, ...

Masimo delivered Q3 results that mostly aligned with guidance, yet it faces challenges in its non-healthcare segment.

“Masimo took shortcuts ... "There's lots of reasons to buy the watch even without the blood oxygen sensor." ...

Masimo (NASDAQ: MASI) today announced that its management will participate in the Jefferies London Healthcare Conference on Thursday, November 21, 2024 at 8:30 a.m. GMT. A live webcast of the ...

Apple and medical device company Masimo are currently embroiled in multiple legal battles, headlined by the ongoing fight over ...

Shares of Masimo Co. (NASDAQ:MASI – Get Free Report) have received an average rating of “Moderate Buy” from the seven ...

We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...

by removing blood oxygen measurement from its flagship smartwatches sold new — a feature that’s still MIA on new devices to this day. On Friday, Apple got a small piece of revenge over Masimo ...